Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-010476

CHIEF ACCOUNTING OFFICER gave up 1,666 shares (to pay taxes)

  • CHIEF ACCOUNTING OFFICER acquired 3,933 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Megna Michael R CHIEF ACCOUNTING OFFICER 2025-04-07 Option exercise +3,933 34,212 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2025-04-07 Shares withheld for taxes −1,666 $20.28 $33,786 32,546 D
Derivatives
Megna Michael R CHIEF ACCOUNTING OFFICER 2025-04-07 Option exercise · Restricted Share Unit −3,933 3,932 D
Loading xslF345X05/form4-04092025_080447.xml…